Sector valuations DaShenLin Pharmaceutical Group Co., Ltd.
Stocks
603233
CNE100002RG2
Drug Retailers
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.40 CNY | -1.55% |
|
-4.42% | +4.43% |
| 04-24 | Dashenlin Pharma's Q1 Profit Rises 11% | MT |
| 04-24 | Dashenlin Pharma's 2025 Profit Jumps 35%, Revenue Rises 4% | MT |
Main competitors
| P/E (N) | Price to Book (N) | PEG (N) | EV / Sales (N) | EV / EBITDA (N) | EV / EBIT (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | 14.34x | 2.69x | 0.69x | 0.59x | 4.72x | 7.8x | 4.82% | 3.14B | |
| 17.64x | 1.56x | 2.19x | 0.73x | 11.56x | 12.41x | -.--% | 15.25B | |
| 23.39x | 2.59x | 3.9x | 0.93x | 16.4x | 16.66x | 0.97% | 7.07B | |
| 16.02x | 1.69x | 1.78x | 0.72x | 7.46x | 9.39x | 2.33% | 5.86B | |
| 13.91x | 2.09x | 0.86x | 0.89x | 6.44x | 8.44x | 3.08% | 3.94B | |
| 13.96x | 4.27x | 6.49x | 1.19x | 7.29x | 13.71x | 5.48% | 3.16B | |
| 14.52x | 6.57x | 2.22x | 0.88x | 6.58x | 9.16x | 4.42% | 2.93B | |
| 38.48x | - | 1.23x | - | - | - | - | 2.5B | |
| 21.26x | 3.72x | 0.92x | 0.61x | 7.89x | 12.92x | 1.93% | 1.52B | |
| -91.41x | 2.88x | 1.49x | 0.46x | 16.95x | 102.96x | 0.01% | 1.5B | |
| 12.1x | 0.86x | 0.12x | 0.29x | 2.78x | 5.73x | 4.2% | 958M | |
| 14.44x | 2.39x | -0.55x | 0.85x | 6.89x | 14.83x | 5.79% | 915M | |
| 40.16x | 4.41x | 0.95x | 1.16x | 13.39x | 25.66x | - | 887M | |
| 25.8x | 7.03x | 0.95x | 0.93x | 12.73x | 19.74x | 1.39% | 768M | |
| 14.33x | 1.93x | 1.18x | 0.69x | 8.41x | 13.57x | 0.36% | 695M | |
| Average | 12.60x | 3.19x | 1.63x | 0.78x | 9.25x | 19.50x | 2.67% | 3.41B | |
| Weighted average by Cap. | 15.58x | 2.57x | 2.21x | 0.79x | 10.13x | 15.04x | 1.92% |
Select your edition
All financial news and data tailored to specific country editions
